These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 22607702)

  • 81. p53 protein expression and prognosis in squamous cell carcinoma of the esophagus.
    Sarbia M; Porschen R; Borchard F; Horstmann O; Willers R; Gabbert HE
    Cancer; 1994 Oct; 74(8):2218-23. PubMed ID: 7922972
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Analysis of HER2 gene amplification and protein expression in esophageal squamous cell carcinoma.
    Zhan N; Dong WG; Tang YF; Wang ZS; Xiong CL
    Med Oncol; 2012 Jun; 29(2):933-40. PubMed ID: 21318736
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Analysis of p53 mutational spectra of esophageal squamous cell carcinomas from Linzhou, comparison with esophageal and other cancers from other areas].
    Wang LD; Liu B; Zheng S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Mar; 24(3):202-5. PubMed ID: 12816712
    [TBL] [Abstract][Full Text] [Related]  

  • 84. p53 protein accumulation and p53 gene mutation in esophageal carcinoma. A molecular and immunohistochemical study with clinicopathologic correlations.
    Coggi G; Bosari S; Roncalli M; Graziani D; Bossi P; Viale G; Buffa R; Ferrero S; Piazza M; Blandamura S; Segalin A; Bonavina L; Peracchia A
    Cancer; 1997 Feb; 79(3):425-32. PubMed ID: 9028350
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Expression of cyclin D1 and p53 and its correlation with proliferative activity in the spectrum of esophageal carcinomas induced after duodenal content reflux and 2,6-dimethylnitrosomorpholine administration in rats.
    Pera M; Fernandez PL; Pera M; Palacín A; Cardesa A; Dasenbrock C; Tillman T; Mohr U
    Carcinogenesis; 2001 Feb; 22(2):271-7. PubMed ID: 11181448
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Apoptotic markers in photoinduced cutaneous carcinoma.
    Abu Juba B; Şovrea A; Crişan D; Melincovici C; Coneac A; Badea M; Crişan M
    Rom J Morphol Embryol; 2013; 54(3 Suppl):741-7. PubMed ID: 24322021
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Comprehensive assessment of prognostic markers for sinonasal squamous cell carcinoma.
    Takahashi Y; Bell D; Agarwal G; Roberts D; Xie TX; El-Naggar A; Myers JN; Hanna EY
    Head Neck; 2014 Aug; 36(8):1094-102. PubMed ID: 23836481
    [TBL] [Abstract][Full Text] [Related]  

  • 88. p53 immunohistochemical expression and patient prognosis in esophageal squamous cell carcinoma.
    Murata A; Baba Y; Watanabe M; Shigaki H; Miyake K; Karashima R; Imamura Y; Ida S; Ishimoto T; Iwagami S; Sakamoto Y; Miyamoto Y; Yoshida N; Baba H
    Med Oncol; 2013 Dec; 30(4):728. PubMed ID: 24026664
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous cell carcinoma.
    Sunpaweravong P; Sunpaweravong S; Puttawibul P; Mitarnun W; Zeng C; Barón AE; Franklin W; Said S; Varella-Garcia M
    J Cancer Res Clin Oncol; 2005 Feb; 131(2):111-9. PubMed ID: 15672286
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The role of p63 and deltaNp63 (p40) protein expression and gene amplification in esophageal carcinogenesis.
    Geddert H; Kiel S; Heep HJ; Gabbert HE; Sarbia M
    Hum Pathol; 2003 Sep; 34(9):850-6. PubMed ID: 14562279
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Immunohistochemical MUC1 (DF3 antigen) expression of human esophageal squamous cell carcinoma.
    Kijima H; Chino O; Oshiba G; Tanaka H; Kenmochi T; Kise Y; Shimada H; Abe Y; Tokunaga T; Yamazaki H; Nakamura M; Tanaka M; Makuuchi H; Ueyama Y
    Anticancer Res; 2001; 21(2B):1285-9. PubMed ID: 11396200
    [TBL] [Abstract][Full Text] [Related]  

  • 92. FGFR1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal Carcinoma.
    von Loga K; Kohlhaussen J; Burkhardt L; Simon R; Steurer S; Burdak-Rothkamm S; Jacobsen F; Sauter G; Krech T
    PLoS One; 2015; 10(11):e0141867. PubMed ID: 26555375
    [TBL] [Abstract][Full Text] [Related]  

  • 93. beta-Catenin splice variants and downstream targets as markers for neoplastic progression of esophageal cancer.
    Roth MJ; Hu N; Johnson LL; Quon-Hang W; Ahnen DJ; Iwamoto M; Dawsey SM; Taylor PR; Huppi K
    Genes Chromosomes Cancer; 2005 Dec; 44(4):423-8. PubMed ID: 16114033
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Analysis on the clinical features of 22 basaloid squamous cell carcinoma of the lung.
    Wang LC; Wang L; Kwauk S; Woo JA; Wu LQ; Zhu H; Zhan LZ; Sun NL; Zhang L
    J Cardiothorac Surg; 2011 Jan; 6():10. PubMed ID: 21269455
    [TBL] [Abstract][Full Text] [Related]  

  • 95. High prevalence of p53 gene alterations and protein overexpression in human esophageal cancer: correlation with dietary risk factors in India.
    Gaur D; Arora S; Mathur M; Nath N; Chattopadhaya TK; Ralhan R
    Clin Cancer Res; 1997 Nov; 3(11):2129-36. PubMed ID: 9815606
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Lung squamous cell carcinomas with basaloid histology represent a specific molecular entity.
    Brambilla C; Laffaire J; Lantuejoul S; Moro-Sibilot D; Mignotte H; Arbib F; Toffart AC; Petel F; Hainaut P; Rousseaux S; Khochbin S; de Reyniès A; Brambilla E
    Clin Cancer Res; 2014 Nov; 20(22):5777-86. PubMed ID: 25189482
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Galectin-7: will the lectin's activity establish clinical correlations in head and neck squamous cell and basal cell carcinomas?
    Cada Z; Chovanec M; Smetana K; Betka J; Lacina L; Plzák J; Kodet R; Stork J; Lensch M; Kaltner H; André S; Gabius HJ
    Histol Histopathol; 2009 Jan; 24(1):41-8. PubMed ID: 19012243
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Correlation between p53 gene mutations and p53 protein overexpression in esophageal squamous cell carcinoma].
    Li G; Liu ZX; Huang J; Wang JM; Wang QH
    Zhonghua Bing Li Xue Za Zhi; 2005 Dec; 34(12):802-4. PubMed ID: 16545191
    [No Abstract]   [Full Text] [Related]  

  • 99. Evaluating the Correlation Between the Survival Rate of Patients with Esophageal Squamous Cell Carcinoma and Expression of p53 and Cyclin D1 Biomarkers Along with Other Prognostic Factors.
    Saemi N; Khoshnevis J; Akbari ME; Meysamie A; Korourian A; Gholizadeh B; Larijani L; Moradi A; Baikpour M; Baikpour M; Zham H
    J Gastrointest Cancer; 2018 Mar; 49(1):35-40. PubMed ID: 27975182
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [Detection and significance of epidermal growth factor receptor mutation in esophageal, esophagogastric junction and gastric cancers].
    Lyu X; Huang J; Liu J; Wang W; Su Y; Zhang W; Sun Y; Ying J; Wang J; Sun Y
    Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):346-50. PubMed ID: 25030589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.